Baccinex
Baccinex is a full-service pharmaceutical contract manufacturing organization (CDMO) headquartered in Courroux, Switzerland, specializing in aseptic fill-finish of sterile liquid and lyophilized products for biotech and pharmaceutical clients across clinical and commercial stages.
- Company typePrivate
- Founded1999
- HeadquartersCourroux, Switzerland
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What Baccinex does
Baccinex is a full-service pharmaceutical contract manufacturing organization (CDMO) headquartered in Courroux, Switzerland. Founded in 1999, the company sits within a globally distributed CDMO platform that operates seven manufacturing sites across Switzerland (Courroux/Jura — heritage facility), France (Livron-sur-Drôme, Maisons-Alfort), Germany (Leipzig — corporate headquarters), Norway (Halden), Greece (Athens), and Japan (Kawagoe). The firmographic employee range is 1,001-5,000, though the Courroux site alone is cited at 110+ professionals across more than 20 disciplines on a 6,200 m² industrial footprint.
The company's technical core is aseptic fill-finish manufacturing of sterile pharmaceutical products filled into vials, in both lyophilized (freeze-dried) and liquid formats. Capabilities include lyophilization cycle development supported by a 3.5 m² lyophilizer, aseptic process simulation (media fills), formulation of complex modalities (peptides, biologics, monoclonal antibodies, controlled substances, small molecules, sterile suspensions, ophthalmics), and a broad in-house analytical release toolkit (HPLC/UPLC, Karl Fischer, sub-visible particle counting, SDS-PAGE, endotoxin and bioburden testing, sterility under isolator). The Courroux facility is dual-certified by Swissmedic (EU-GMP) and US-FDA. A no-minimum-batch-size policy and bulk-volume capacity from 200-300 ml position the firm for early-stage clinical customers, while commercial offerings extend to prefilled syringes, ampoules, IV bags, oral liquids, semi-solids, oral solids, and suppositories across the broader site network.
Baccinex operates a project-based B2B services model, billing on clinical production (Phase I/II/III), commercial production, analytical services, regulatory support, and packaging, with multi-year contracts and transparent quote-based pricing. Go-to-market is direct enterprise engagement with (bio)pharmaceutical companies of all sizes, supplemented by content marketing (Adragos Hub blog), industry events, and LinkedIn/YouTube presence. Customer evidence indicates a biotech-to-commercial relationship pattern — for example, the partnership with Igyxos to manufacture the first clinical batch of a first-in-class infertility mAb, which advanced into clinical phases and led to repeat production engagements.
Baccinex firmographics
Firmographics- Name
- Baccinex
- Website
- https://baccinex.com
- Company type
- Private
- Founded year
- 1999
- Headcount range
- 1,001–5,000 employees
- Short description
- Baccinex is a full-service pharmaceutical contract manufacturing organization (CDMO) headquartered in Courroux, Switzerland, specializing in aseptic fill-finish of sterile liquid and lyophilized products for biotech and pharmaceutical clients across clinical and commercial stages.
- Ownership category
- akta.pro rank
Baccinex industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH)
- akta.pro secondary industries
- Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Biologics (mAbs/Recombinant Proteins) CDMO (HLAGABAC), Drug Substance–Drug Product Integrated CDMO (HLAGABAG)
Keywords
Where Baccinex is headquartered
LocationHeadquarters
- HQ city
- Courroux
- HQ country
- Switzerland
- HQ region
- Europe
Offices7 records
Markets served
Baccinex business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Contract Manufacturing Services: Revenue generated through contract manufacturing services as a CDMO (Contract Development and Manufacturing Organization). Services include clinical production (Phase I, II, III), commercial production, analytical services, regulatory support, and packaging services. Billed based on project scope, batch size, and service complexity.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Baccinex product offering
Product offeringCore offering
Baccinex is a full-service pharmaceutical contract manufacturing organization (CDMO) founded in 1999 in Courroux, Switzerland, specializing in aseptic manufacturing of sterile liquid and lyophilized (freeze-dried) pharmaceutical products. The company provides clinical production (Phase I, II, III), commercial production, lyophilization cycle development, analytical services, regulatory support, visual inspection, pharmaceutical packaging, controlled substance handling, cold chain distribution, and stability studies for biotechnology and pharmaceutical companies.
Differentiator
Problem solved
Functional benefit
Products and services
- Aseptic Fill-Finish Manufacturing
Companies that use Baccinex
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Baccinex technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Baccinex partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- IgyxosminorIgyxos, a biotech company developing first-in-class monoclonal antibodies for infertility treatment, engaged Adragos Pharma as CDMO to produce their first clinical batch. The collaboration successfully advanced the mAb project into clinical phases, leading to additional production engagements.
Scale indicators6 records
Recent moves5 records
Expansion highlights5 records
Baccinex competitors and assessment
Company assessmentDirect peers
- Vetter Pharma: German-headquartered specialist in aseptic fill-finish of syringes, vials, and lyophilized biologics for clinical and commercial supply — directly comparable in core sterile manufacturing capability and customer profile to Baccinex.
- Recipharm: European CDMO with sterile injectable and lyophilization capabilities serving pharma and biotech customers across clinical and commercial production — closely aligned in service mix and customer segment.
- Aenova: German-headquartered CDMO offering sterile liquid and lyophilized fill-finish, oral solids, and semi-solids — direct competitor in European contract sterile manufacturing for pharma/biotech.
- Fareva: French-headquartered CDMO with sterile injectable and lyophilization capabilities across multiple European sites — directly comparable in aseptic fill-finish services and biotech customer base.
- Delpharm: European contract manufacturer of sterile and non-sterile pharmaceutical forms including injectables and lyophilized products — comparable in formulation and fill-finish offerings.
- Simtra BioPharma Solutions: US-based CDMO focused on sterile injectable fill-finish and lyophilization for biopharma — directly comparable in sterile manufacturing core, with overlapping biotech customer profile.
- Carbogen Amcis: Swiss CDMO with sterile injectable and aseptic manufacturing capabilities — directly comparable in geographic positioning, regulatory profile, and biotech customer focus.
- Almac Group: UK/Northern Ireland-based CDMO with aseptic fill-finish, lyophilization, and clinical supply services for pharma and biotech — directly comparable in clinical-stage sterile manufacturing services.
Broad incumbents
- Catalent: Global CDMO with significant sterile fill-finish and lyophilization capacity for biologics across clinical and commercial stages — broader portfolio but directly overlaps Baccinex's core service offering.
- CordenPharma: European CDMO offering sterile injectables, peptides, and biologics manufacturing — broader portfolio but significant overlap with Baccinex's sterile and peptide capabilities.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Baccinex social profiles
Digital presenceBaccinex financial estimates
Financial estimateRevenue estimate
Valuation estimate
Baccinex leadership team
Management profileNumber of profiles
Baccinex funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Baccinex M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Baccinex
What does Baccinex do?
Baccinex is a full-service pharmaceutical contract manufacturing organization (CDMO) founded in 1999 in Courroux, Switzerland, specializing in aseptic manufacturing of sterile liquid and lyophilized (freeze-dried) pharmaceutical products. The company provides clinical production (Phase I, II, III), commercial production, lyophilization cycle development, analytical services, regulatory support, visual inspection, pharmaceutical packaging, controlled substance handling, cold chain distribution, and stability studies for biotechnology and pharmaceutical companies.
When was Baccinex founded?
Baccinex was founded in 1999. It employs 1,001 to 5,000 people.
Where is Baccinex based?
Baccinex is headquartered in Courroux, Switzerland, in the Europe region.
How does Baccinex make money?
One revenue line is on record: contract Manufacturing Services.
Who are Baccinex's main competitors?
Direct peers on record are Vetter Pharma, Recipharm, Aenova, Fareva, Delpharm, Simtra BioPharma Solutions, Carbogen Amcis and Almac Group. Broad incumbents are Catalent and CordenPharma.
Does Baccinex have an API?
No public API is recorded for Baccinex.
What industry is Baccinex in?
Baccinex's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO, with a secondary code of HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 325412 and its SIC code is 2834.